CREATOGEN AG has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are SHENGYUAN GENE DEV CO LTD SHAN, SHANGHAI BIORIGIN GENE DEV CO and EMERGENT PRODUCT DEV UK LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 | |
#6 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Apfel Heiko | 11 |
#2 | Trebesius Karlheinz | 6 |
#3 | Fuchs Thilo M | 3 |
#4 | Hueck Christoph | 3 |
#5 | Medina Eva | 3 |
#6 | Guzman Carlos Alberto | 3 |
#7 | Hensel Michael | 3 |
#8 | Haas Rainer | 3 |
#9 | Autenrieth Ingo | 3 |
#10 | Niesalla Heide S | 2 |
Publication | Filing date | Title |
---|---|---|
WO02092814A2 | Screening method for attenuating or virulence defective microbial cells | |
WO02083940A2 | Screening method for anti-microbial drug targets by genome-saturing mutagenesis (gsm) | |
DE19955303A1 | Test of microorganisms | |
CA2341349A1 | Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof | |
BR9910646A | Detection of antibiotic resistance in microorganisms |